Prices as of 2025-09-18 16:00:04 ET
Ticker Appearances
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 9c4fdd-fa29cc-a7e303-5d49f1-678691
Visitor: 9c4fdd-fa29cc-a7e303-5d49f1-678691 Array ( [cookie] => 9c4fdd-fa29cc-a7e303-5d49f1-678691 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.34 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 9c4fdd-fa29cc-a7e303-5d49f1-678691
Visitor: 9c4fdd-fa29cc-a7e303-5d49f1-678691 Array ( [cookie] => 9c4fdd-fa29cc-a7e303-5d49f1-678691 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.34 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 9c4fdd-fa29cc-a7e303-5d49f1-678691
Visitor: 9c4fdd-fa29cc-a7e303-5d49f1-678691 Array ( [cookie] => 9c4fdd-fa29cc-a7e303-5d49f1-678691 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.34 )
Daily Technical Strategy
Short-term Bounce underway into next week
A short-term bounce looks to be underway in US Equities that likely carries prices higher into 9/14 and should reach at least 4125-4150. Following a...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 9c4fdd-fa29cc-a7e303-5d49f1-678691
Visitor: 9c4fdd-fa29cc-a7e303-5d49f1-678691 Array ( [cookie] => 9c4fdd-fa29cc-a7e303-5d49f1-678691 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.34 )
Daily Technical Strategy
Tech Hardware favored over Software; Meanwhile Pharma/Biotech slides further
NEAR-TERM AND INTERMEDIATE-TERM TECHNICAL TRENDS REMAIN BULLISH FOR US EQUITIES, AND WEDNESDAY’S BOUNCE MADE SUFFICIENT PROGRESS TO HELP ESTABLISH A NEW SHORT-TERM UPTREND, WHICH ARGUABLY...
This report is accessible to FSI Pro, FSI Macro memberships.
You have viewed the limit of 2 reports for free this month.
To continue reading our research please sign up below.
Already have an account? Sign In 9c4fdd-fa29cc-a7e303-5d49f1-678691
Visitor: 9c4fdd-fa29cc-a7e303-5d49f1-678691 Array ( [cookie] => 9c4fdd-fa29cc-a7e303-5d49f1-678691 [current_usage] => 2 [max_usage] => 2 [current_usage_crypto] => 2 [max_usage_crypto] => 2 [lock] => 1 [message] => [error] => [active_member] => 0 [subscriber] => 0 [role] => [user_id] => [IP] => 216.73.216.34 )
